参考文献/References:
[1]张波.控制性卵巢刺激中卵巢慢反应的发生原因及处理方法 [J].生殖医学杂志,2013,22(10):770-774.
[2]乔杰,马彩虹,刘嘉茵,等.辅助生殖促排卵药物治疗专家共识 [J].生殖与避孕,2015,35(4):211-223.
[3]尹倩倩,李予,黄佳,等.LH受体基因rsl3405728位点多态性与卵巢慢反应的相关性 [J].中华医学遗传学杂志,2015,32(6):840-843.
[4]FERRARETTI A P, GIANAROLI L, MAGLI M C, et al. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques [J]. Fertility and Sterility, 2004, 82 (6): 1521-1526.
[5]DE PLACIDO G, ALVIGGI C, PERINO A, et al. Recombinant human LH supplementation versus recombinant human FSH(rFSH)step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH.A multicentre,prospective,randomized controlled trial [J]. Human Reproduction, 2005, 20 (2): 390-396.
[6]李红真,龚斐,蔡素芬,等.卵巢刺激慢反应患者补充重组黄体生成素的疗效评价 [J].生殖医学杂志,2013,22(2):92-96.
[7]帅振虹,连方.补充黄体生成素对控制性超促排卵过程中卵巢慢反应患者临床结局的影响 [J].现代妇产科进展,2014,23(9):716-718, 723.
[8]潘萍,杨冬梓.低剂量绒促性素与控制性卵巢刺激 [J].实用妇产科杂志,2016,32(1):19-22.
[9]Ezcurra D, Humaidan P. A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology [J]. Reprod Biol Endocrinol, 2014,12(1):95.
[10]CHECA M A, JOSE ESPINOS J, REQUENA A. Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis [J]. Fertility and Sterility, 2012, 97 (6): 1343.
[11]Martins WP, Vieira AD, Figueiredo JB, et al. FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques [J]. Cochrane Database Syst Rev,2013,3(3):CD010042.
[12] 杨子凌,姜宏,倪丰.小剂量绒促性素在抵抗型慢反应患者中的应用 [J].实用妇产科杂志,2016,32(11):859-863.
相似文献/References:
[1]杨学妞,张觇宇.动态血清孕酮及β-HCG值对早期异常妊娠的临床意义[J].中国计划生育和妇产科,2010,(06):0.
YANG Xue-niu,ZHANG Chan-yu.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(9):0.
[2]伍洁华,曾少颜.1例注射绒毛膜促性腺激素后严重反应的护理[J].中国计划生育和妇产科,2011,(03):0.
[3]赵振钏*,亓蓉,吴小华,等.卵巢刺激慢反应患者补充生长激素的疗效评价[J].中国计划生育和妇产科,2019,(7):41.
ZHAO Zhen-chuan*,QI Rong,WU Xiao-hua,et al.Efficacy evaluation of supplementation of growth hormone in patients with suboptimal ovarian response[J].Chinese Journal of Family Planning & Gynecotokology,2019,(9):41.